Aldeyra Therapeutics Company
Aldeyra Therapeutics develops next-generation medicines to improve the lives of patients with immune-mediated diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Burlington, Massachusetts, United States
Founded Date:
2004-01-01
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
267491560
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership